The U. S. Fish and Wildlife Service’s Aquatic Animal Drug Approval Partnership (AADAP) Program is working with a variety of public data-generating partners and drug sponsors to identify and obtain approval of a sedative(s) for immediate-release use in fish. Two candidate products, AQUI-S® E (50% eugenol) and AQUI-S® 20E (10% eugenol), have been developed by AQUI-S New Zealand, Ltd. (Lower Hutt, NZ), and preliminary data and research protocols are being developed to evaluate their efficacy and safety.
Publication date
Type of document
Fact Sheet
Program